Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: E9AGP1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 111 | 115 | PF00656 | 0.601 |
CLV_C14_Caspase3-7 | 36 | 40 | PF00656 | 0.529 |
CLV_NRD_NRD_1 | 96 | 98 | PF00675 | 0.749 |
CLV_PCSK_KEX2_1 | 98 | 100 | PF00082 | 0.626 |
CLV_PCSK_PC1ET2_1 | 98 | 100 | PF00082 | 0.582 |
CLV_PCSK_SKI1_1 | 17 | 21 | PF00082 | 0.404 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.490 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.511 |
DOC_CYCLIN_RxL_1 | 4 | 14 | PF00134 | 0.511 |
DOC_MAPK_MEF2A_6 | 42 | 49 | PF00069 | 0.485 |
DOC_WW_Pin1_4 | 54 | 59 | PF00397 | 0.512 |
LIG_14-3-3_CanoR_1 | 17 | 22 | PF00244 | 0.479 |
LIG_14-3-3_CanoR_1 | 42 | 48 | PF00244 | 0.460 |
LIG_AP2alpha_2 | 82 | 84 | PF02296 | 0.414 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.481 |
LIG_BRCT_BRCA1_1 | 105 | 109 | PF00533 | 0.594 |
LIG_BRCT_BRCA1_1 | 45 | 49 | PF00533 | 0.464 |
LIG_FHA_1 | 84 | 90 | PF00498 | 0.439 |
LIG_FHA_2 | 20 | 26 | PF00498 | 0.466 |
LIG_FHA_2 | 85 | 91 | PF00498 | 0.659 |
LIG_FHA_2 | 9 | 15 | PF00498 | 0.537 |
LIG_IRF3_LxIS_1 | 29 | 36 | PF10401 | 0.383 |
LIG_MLH1_MIPbox_1 | 45 | 49 | PF16413 | 0.380 |
LIG_NRBOX | 28 | 34 | PF00104 | 0.442 |
LIG_NRBOX | 5 | 11 | PF00104 | 0.508 |
LIG_PDZ_Class_1 | 112 | 117 | PF00595 | 0.607 |
LIG_Pex14_1 | 80 | 84 | PF04695 | 0.421 |
LIG_PTB_Apo_2 | 63 | 70 | PF02174 | 0.388 |
LIG_PTB_Phospho_1 | 63 | 69 | PF10480 | 0.387 |
LIG_SH2_STAP1 | 69 | 73 | PF00017 | 0.371 |
LIG_TRAF2_1 | 72 | 75 | PF00917 | 0.444 |
LIG_UBA3_1 | 62 | 68 | PF00899 | 0.443 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.489 |
MOD_CK2_1 | 24 | 30 | PF00069 | 0.525 |
MOD_CK2_1 | 69 | 75 | PF00069 | 0.427 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.396 |
MOD_CK2_1 | 84 | 90 | PF00069 | 0.415 |
MOD_GlcNHglycan | 25 | 29 | PF01048 | 0.470 |
MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.571 |
MOD_GSK3_1 | 108 | 115 | PF00069 | 0.707 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.503 |
MOD_N-GLC_1 | 50 | 55 | PF02516 | 0.569 |
MOD_NEK2_1 | 33 | 38 | PF00069 | 0.391 |
MOD_NEK2_1 | 49 | 54 | PF00069 | 0.534 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.556 |
MOD_NEK2_2 | 19 | 24 | PF00069 | 0.402 |
MOD_NEK2_2 | 43 | 48 | PF00069 | 0.355 |
MOD_PKA_2 | 33 | 39 | PF00069 | 0.455 |
MOD_PKA_2 | 41 | 47 | PF00069 | 0.507 |
MOD_PKB_1 | 99 | 107 | PF00069 | 0.617 |
MOD_Plk_2-3 | 103 | 109 | PF00069 | 0.598 |
MOD_Plk_4 | 43 | 49 | PF00069 | 0.488 |
MOD_ProDKin_1 | 54 | 60 | PF00069 | 0.505 |
MOD_SUMO_rev_2 | 90 | 100 | PF00179 | 0.540 |
TRG_DiLeu_BaEn_4 | 74 | 80 | PF01217 | 0.461 |
TRG_NLS_MonoExtC_3 | 97 | 103 | PF00514 | 0.574 |
TRG_NLS_MonoExtN_4 | 97 | 102 | PF00514 | 0.632 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAA9 | Leptomonas seymouri | 63% | 92% |
A0A3S5H6Y4 | Leishmania donovani | 100% | 100% |
A0A422NPT6 | Trypanosoma rangeli | 30% | 75% |
A4H8P1 | Leishmania braziliensis | 81% | 100% |
E9ACR6 | Leishmania major | 89% | 100% |
E9AQS5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 96% |